D. E. Shaw & Co., Inc. Rubius Therapeutics, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$22.26 - $28.43 $667,800 - $852,900	-30,000 Reduced 60.0%	20,000 $488,000
Q1 2021 May 17, 2021	BUY	$8.02 - $32.01 $401,000 - $1.6 Million	50,000 New	50,000 $1.33 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.